Clinico-immunologic effect of tactivin in chronic myeloid leukemia
Abdulkadyrov KM, Guseva SA · 1994 · Gematologiia i transfuziologiia 1994
Reported findings and study design
Adjunctive Tactivin was reported to improve cellular immunity and reduce infectious complications 1.77-fold. The abstract gives no raw infection counts or comparison-arm sizes.
35 advanced chronic-myeloid-leukemia patients underwent immune assessment around myelosan chemotherapy.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Infectious complications | 1.77-fold reduction reported | Raw events and comparator denominator not supplied |
| Assessed population | 35 patients with advanced CML |
A historical adjunctive report, not evidence of leukemia control or survival benefit. The fold claim cannot be converted into absolute risk without denominators.
Source for the extracted data ↗ · Checked 2026-11-01
Molekul summary of the linked publication. Educational information, not medical advice. Seek qualified healthcare help for medical conditions.
Methods, limitations & source review
Study limitations
- A historical adjunctive report, not evidence of leukemia control or survival benefit. The fold claim cannot be converted into absolute risk without denominators.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Review depth: Indexed abstract checked
Source access and review scope
Original-publication metadata and indexed abstract checked in Europe PMC. No unavailable full-text figures inferred.
Recorded source-check date: 2026-11-01. This date does not imply a completed systematic review.
Source type: Journal publication
Citation and original source
Original source: Abdulkadyrov KM, Guseva SA. Clinico-immunologic effect of tactivin in chronic myeloid leukemia Gematologiia i transfuziologiia 1994 1994.
Molekul research summary: https://molekul.io/research/thin-7896024. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry